Prognostic significance of individual COVADIS criteria in patients undergoing acetylcholine provocation testing

Riccardo Rinaldi1,2, Michele Russo2,3, Ilaria Torre2

  • 1Cardiology Unit, Infermi Hospital, Rimini, Italy.

Insights

The prognostic significance of Coronary Vasomotor Disorders International Study Group (COVADIS) criteria in patients with myocardial ischemia and non-obstructive coronary arteries is best assessed by analyzing individual components rather than a simple positive/negative stratification. This approach offers improved prognostic stratification and personalized treatment strategies.

Area of Science:

  • Cardiology
  • Diagnostic Testing
  • Clinical Prognosis

Background:

  • The prognostic value of Coronary Vasomotor Disorders International Study Group (COVADIS) criteria during acetylcholine (ACh) provocation testing remains uncertain.
  • Patients with INOCA (ischemia with non-obstructive coronary arteries) or MINOCA (myocardial infarction with non-obstructive coronary arteries) often undergo ACh testing.

Purpose of the Study:

  • To evaluate the prognostic impact of COVADIS criteria in patients with INOCA or MINOCA undergoing ACh provocation testing.
  • To determine if a comprehensive analysis of COVADIS criteria components improves outcome prediction.

Main Methods:

  • Consecutive INOCA and MINOCA patients undergoing ACh provocation testing were enrolled.
  • The presence of individual COVADIS criteria was recorded.
  • Major adverse cardiovascular and cerebrovascular events (MACCE) were tracked for primary outcome assessment.

Main Results:

  • Among 519 patients, 52.8% had a positive ACh test. MACCE incidence increased with the number of positive COVADIS criteria (0 criteria: 3.1%; 1: 9.2%; 2: 10.3%; 3: 15.4%).
  • Patients with one or more positive criteria had significantly higher MACCE rates (12.5% vs 3.1%).
  • Epicardial coronary diameter reduction ≥90% and MINOCA were independent MACCE predictors. In negative ACh tests, ≥90% diameter reduction was the sole predictor, with ≥1 COVADIS criteria indicating higher MACCE risk.

Conclusions:

  • The study challenges a binary (positive/negative) interpretation of COVADIS criteria.
  • A detailed analysis of individual COVADIS criteria components provides superior prognostic stratification.
  • Personalized treatment strategies can be enhanced by this comprehensive approach.
Abstract

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
589
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
299
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.6K